Respiratory Viral Immunisation
Research activity includes COVID-19 and influenza vaccine combinations, with interest in immune responses in older adults and seasonal protection against circulating respiratory viruses.
- COVID-19 vaccines
- Influenza vaccination
- Humoral immune response
The sponsor’s work in this area reflects a focus on vaccine-related immunogenicity and co-administration strategies for common respiratory infections.
Arboviral and Emerging Infection Vaccines
Clinical research also extends to Rift Valley fever infection, supporting vaccine development for a medically important viral zoonosis with potential public health impact.
- Rift Valley fever vaccine
- Live attenuated vaccines
- Emerging infectious diseases
This area centres on prevention of severe viral disease through immunisation approaches targeting high-concern pathogens.
Adjuvanted Vaccine Combinations
Trials funded by the sponsor include evaluation of MF59-adjuvanted influenza vaccines alongside SARS-CoV-2 immunisation, with attention to vaccine pairing in routine adult care.
- Adjuvanted seasonal influenza vaccines
- Vaccine co-administration
- Seasonal vaccination strategies
These studies align with interest in optimising vaccine-induced immunity across overlapping respiratory vaccination needs.
